Brief: LifeMD Sees FY revenue USD 148-149 million
08/11/2023 22:52
Nov 8 (Reuters) - LifeMD Q3 revenue USD 38.6 million vs. IBES estimate USD 38.2 million. * Outlook FY revenue USD 148-149 million * Q3 adjusted EPS USD 0.08 * Q3 gross margin 88% * Outlook FY adjusted EBITDA USD 10-11 million * Q3 adjusted EBITDA USD 2.8 million * Q3 net income USD -6.9 million
Recent news on LifeMD
See all newsLifeMD Inc reports results for the quarter ended June 30 - Earnings Summary
LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs
Brief: LifeMD Inc Q2 Revenue USD 47.3 Million Vs. IBES Estimate USD 49.2 Million
LifeMD Inc expected to post a loss of 15 cents a share - Earnings Preview
LifeMD Q1 revenue beats estimates on record telehealth subscriber additons